Live Breaking News & Updates on Fulgent genetics inc

Stay informed with the latest breaking news from Fulgent genetics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Fulgent genetics inc and stay connected to the pulse of your community

Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024

Fulgent Genetics, Inc. ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its first quarter 2024 financial...

Nasdaq , Fulgent-genetics-inc , Conference-call , Announce-first-quarter , Investor-relations ,

Fulgent Genetics (NASDAQ:FLGT) Reaches New 1-Year Low at $21.20

Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $21.20 and last traded at $21.23, with a volume of 41521 shares traded. The stock had previously closed at $21.70. Wall Street Analyst Weigh In Several analysts have recently […]

United-states , Piper-sandler , Covestor-ltd , Geneos-wealth-management-inc , Fulgent-genetics-inc , Nasdaq , Asset-management-one-co , Lazard-asset-management , Fulgent-genetics , Get-free-report , Capital-management , Wealth-management

Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month Low at $21.20

Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Free Report) reached a new 52-week low on Monday . The stock traded as low as $21.20 and last traded at $21.23, with a volume of 41521 shares traded. The stock had previously closed at $21.70. Analysts Set New Price Targets FLGT has been the subject of […]

United-states , Piper-sandler , Geneos-wealth-management-inc , Covestor-ltd , Fulgent-genetics-company-profile , Fulgent-genetics-inc , Nasdaq , Lazard-asset-management , Asset-management-one-co , Fulgent-genetics , Get-free-report , Capital-management

Fulgent Genetics (NASDAQ:FLGT) Reaches New 1-Year Low at $21.20

Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Free Report) shares hit a new 52-week low during mid-day trading on Monday . The stock traded as low as $21.20 and last traded at $21.23, with a volume of 41521 shares traded. The stock had previously closed at $21.70. Wall Street Analyst Weigh In Several analysts have recently […]

United-states , Piper-sandler , Covestor-ltd , Geneos-wealth-management-inc , Lazard-asset-management , Fulgent-genetics-inc , Nasdaq , Asset-management-one-co , Fulgent-genetics , Get-free-report , Capital-management , Wealth-management

Fulgent Genetics (NASDAQ:FLGT) PT Lowered to $25.00 at Piper Sandler

Fulgent Genetics (NASDAQ:FLGT – Free Report) had its price target decreased by Piper Sandler from $28.00 to $25.00 in a research note released on Wednesday morning, Benzinga reports. Piper Sandler currently has a neutral rating on the stock. Separately, UBS Group started coverage on Fulgent Genetics in a research report on Thursday, December 7th. They […]

United-states , Jian-xie , Piper-sandler , Nuveen-asset-management , Vanguard-group-inc , Pricet-rowe-associates-inc , Barclays-plc , Securities-exchange-commission , Fulgent-genetics-inc , Fulgent-genetics , Free-report , Genetics-stock-down

North American Morning Briefing: Stock Futures -2-

North American Morning Briefing: Stock Futures -2-
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Piper-sandler , Gogo-inc , Topbuild-corp , Bandwidth-inc , Allovir-inc , Ecovyst-inc , Group-inc , Escalade-inc , United-parks-resorts-inc , Blackstone-secured-lending-fund , Novavax-inc , Kontoor-brands-inc

Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results

Full Year 2023 Total Revenue of $289.2 million; Q4 2023 Total Revenue of $70.5 million

Full Year 2023 Core Revenue grows 44% year-over-year to $262.1 million; Q4 2023 Core Revenue grows 21%...

United-states , America , Paul-kim , Ming-hsieh , Fulgent-genetics-inc , Nasdaq , Exchange-commission , Fulgent-genetics , Core-revenue , Chief-executive-officer , Precision-diagnostics , Investigational-new-drug

Fulgent Genetics Inc (FLGT) Faces GAAP Loss Despite Core Revenue Growth in 2023

Core Business Expansion and Strong Cash Position Highlighted Amidst Overall Net Loss

Ming-hsieh , Paul-kim , Fulgent-genetics-inc , Analysis-of-fulgent-genetics-inc-performance , Financial-performance , Chief-executive , Genetics-inc , Revenue-growth , Ore-business , Ash-position , Enetic-testing , Herapeutic-development

Fulgent Genetics (NASDAQ:FLGT) Shares Down 7.8%

Fulgent Genetics (NASDAQ:FLGT) Shares Down 7.8%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Montreal , Quebec , Canada , United-states , Paul-kim , Jian-xie , Securities-exchange-commission , Nasdaq , Raymond-james-financial-services-advisors-inc , Fulgent-genetics-inc , Jpmorgan-chase-co , Raymond-james-associates

Fulgent Genetics (NASDAQ:FLGT) Updates FY 2024 Earnings Guidance

Fulgent Genetics (NASDAQ:FLGT – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of -1.050–1.050 for the period, compared to the consensus EPS estimate of -0.950. The company issued revenue guidance of $280.0 million-$280.0 million, compared to the consensus revenue estimate of $294.2 million. Fulgent Genetics also updated […]

United-states , Jian-xie , Paul-kim , Nuveen-asset-management , Fulgent-genetics-inc , Nasdaq , Pricet-rowe-associates-inc , Barclays-plc , Vanguard-group-inc , Securities-exchange-commission , Fulgent-genetics , Get-free-report